The Valley Desk

NCT02386501 · Interventional trial

Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions HER2 Expressing Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov